# Comparison of Novo Rapid 30 Mix Injection FlexPen® and Humalog 25 Mix Injection KwikPen® in Type 2 Diabetic Patients

> **NCT00806975** · NA · UNKNOWN · sponsor: **Nagaoka Red Cross Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Diabetes Complications
- Diabetes Mellitus, Type 2

## Interventions

- **DEVICE:** KwikPen® and FlexPen®

## Key facts

- **NCT ID:** NCT00806975
- **Lead sponsor:** Nagaoka Red Cross Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2008-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00806975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00806975, "Comparison of Novo Rapid 30 Mix Injection FlexPen® and Humalog 25 Mix Injection KwikPen® in Type 2 Diabetic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00806975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*